Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    Open Studies | "Fibrocystic Breast Disease"
Show Display Options
Rank Status Study
1 Recruiting A Randomized Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Potential Effects of the Dietary Supplement Violet™ Molecular Iodine (I2) on Breast Health in Women With Cyclic Breast Discomfort and Tenderness
Condition: Fibrocystic Breast Condition (FBC)
Interventions: Dietary Supplement: Violet™ Molecular Iodine (I2);   Other: Placebo
2 Not yet recruiting Cystic Breast Masses by Contrast Enhanced Ultrasound (CEUS)
Condition: Breast Cancer
Intervention: Drug: Definity
3 Recruiting A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule
Condition: Fibrocystic Disease of Breast
Interventions: Drug: Xiaoru Sanjie capsules;   Drug: Xiao Yao pills
4 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
5 Recruiting Johns Hopkins Breast Cancer Program Longitudinal Repository
Conditions: Breast Cancer;   Benign Breast Disease
Intervention: Procedure: Sample collection

Study has passed its completion date and status has not been verified in more than two years.